Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark D Minden

Showing results (1-10 of 308) with videos related to

Pageof 31
Sort By:
Stem Cells and Development|March 8, 2011
Dr. Ernest McCullochMark D Minden, Armand Keating
Current Opinion in Hematology|January 10, 2015
Preleukemia: the normal side of cancerLiran I Shlush, Mark D Minden
Experimental Hematology|August 31, 2006
Constitutive phosphorylation of the S6 ribosomal protein via mTOR and ERK signaling in the peripheral blasts of acute leukemia patientsSue Chow, Mark D Minden, David W Hedley
Journal of Food Biochemistry|August 16, 2021
Avocado-derived avocadyne is a potent inhibitor of fatty acid oxidationMatthew Tcheng, Mark D Minden, Paul A Spagnuolo
British Journal of Haematology|July 1, 2015
CD33, not early precursor T-cell phenotype, is associated with adverse outcome in adult T-cell acute lymphoblastic leukaemiaRobert J Guo, Mohammad Bahmanyar, Mark D Minden, et al.
Biochimica Et Biophysica Acta|September 25, 2012
Suspected leukemia oncoproteins CREB1 and LYL1 regulate Op18/STMN1 expressionSerban San-Marina, Youqi Han, Jian Liu, et al.
Oncogene|August 3, 2004
Transcriptional activation of c-myc proto-oncogene by WT1 proteinYouqi Han, Serban San-Marina, Jian Liu, et al.
Blood|January 22, 2010
An upstream insulator regulates DLK1 imprinting in AMLHaytham Khoury, Fernando Suarez-Saiz, Samantha Wu, et al.
British Journal of Haematology|December 13, 2019
Mixed phenotype acute leukaemia with predominant myeloid blasts and a small subset of B/myeloid blasts shares the same mutation profileMario Capitano, Jose-Mario Capo-Chichi, Mark D Minden, et al.
Cancer|May 20, 2009
Outcomes and quality of care in acute myeloid leukemia over 40 yearsShabbir M H Alibhai, Marc Leach, Mark D Minden, et al.
Pageof 31

Showing results (1-10 of 308) with videos related to

Sort By:
Pageof 31
Stem Cells and Development|March 8, 2011
Dr. Ernest McCullochMark D Minden, Armand Keating
Current Opinion in Hematology|January 10, 2015
Preleukemia: the normal side of cancerLiran I Shlush, Mark D Minden
Experimental Hematology|August 31, 2006
Constitutive phosphorylation of the S6 ribosomal protein via mTOR and ERK signaling in the peripheral blasts of acute leukemia patientsSue Chow, Mark D Minden, David W Hedley
Journal of Food Biochemistry|August 16, 2021
Avocado-derived avocadyne is a potent inhibitor of fatty acid oxidationMatthew Tcheng, Mark D Minden, Paul A Spagnuolo
British Journal of Haematology|July 1, 2015
CD33, not early precursor T-cell phenotype, is associated with adverse outcome in adult T-cell acute lymphoblastic leukaemiaRobert J Guo, Mohammad Bahmanyar, Mark D Minden, et al.
Biochimica Et Biophysica Acta|September 25, 2012
Suspected leukemia oncoproteins CREB1 and LYL1 regulate Op18/STMN1 expressionSerban San-Marina, Youqi Han, Jian Liu, et al.
Oncogene|August 3, 2004
Transcriptional activation of c-myc proto-oncogene by WT1 proteinYouqi Han, Serban San-Marina, Jian Liu, et al.
Blood|January 22, 2010
An upstream insulator regulates DLK1 imprinting in AMLHaytham Khoury, Fernando Suarez-Saiz, Samantha Wu, et al.
British Journal of Haematology|December 13, 2019
Mixed phenotype acute leukaemia with predominant myeloid blasts and a small subset of B/myeloid blasts shares the same mutation profileMario Capitano, Jose-Mario Capo-Chichi, Mark D Minden, et al.
Cancer|May 20, 2009
Outcomes and quality of care in acute myeloid leukemia over 40 yearsShabbir M H Alibhai, Marc Leach, Mark D Minden, et al.
Pageof 31